AngioDynamics reported quarterly EPS of -$0.07, beating the Zacks consensus loss of -$0.11 by $0.04. The result compares to EPS of $0.03 a year ago, signaling an operating deterioration year-over-year despite the modest consensus beat, likely a modest near-term positive for the stock.
AngioDynamics reported quarterly EPS of -$0.07, beating the Zacks consensus loss of -$0.11 by $0.04. The result compares to EPS of $0.03 a year ago, signaling an operating deterioration year-over-year despite the modest consensus beat, likely a modest near-term positive for the stock.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
